(2R,3R,4S)-5-Fluoro-3-(4-hydroxy-phenyl)-4-methyl-2-{4-[(S)-2-((S)-3-methyl-pyrrolidin-1-yl)-propoxy]-phenyl}-chroman-6-ol

InChIKey	`WGYZSJCMDOXKNM-WYNHLRBOSA-N`
Compound Name	(2R,3R,4S)-5-Fluoro-3-(4-hydroxy-phenyl)-4-methyl-2-{4-[(S)-2-((S)-3-methyl-pyrrolidin-1-yl)-propoxy]-phenyl}-chroman-6-ol
Canonical SMILES	`C[C@H]1CCN([C@@H](C)COc2ccc([C@@H]3Oc4ccc(O)c(F)c4[C@@H](C)[C@@H]3c3ccc(O)cc3)cc2)C1`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	4
Pfam Stratification	Cross-Family
Avg pChEMBL	8.69
Source	ChEMBL;BindingDB;TTD_MultiTarget

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P18505	GABRB1	Homo sapiens	Human	PF02931 PF02932	9.2	pIC50	TTD_MultiTarget
P03372	ESR1	Homo sapiens	Human	PF12743 PF00104 PF02159 PF00105	8.6	IC50	ChEMBL;BindingDB
Q92731	ESR2	Homo sapiens	Human	PF12497 PF00104 PF00105	7.7	IC50	ChEMBL;BindingDB
Q96WX4	erg6	Pneumocystis carinii (strain B80)	Pathogen	PF08241 PF08498	9.2	pIC50	TTD_MultiTarget